Takeda Pharmaceutical's R&D expenditure FY 2013-2022
In fiscal year 2202, the Japanese pharmaceutical company Takeda Pharmaceutical Co., Ltd. recorded R&D expenses of approximately 633 billion Japanese yen. The company focuses mainly on the therapeutic areas of oncology, gastroenterology, and neuroscience.